Patent · US Active

Pyrrolopyrimidine derivatives as TAM inhibitors

US11136326B2 · kind B2 · utility

6Cited by

8References

31Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Yun-Long Li · Chadds Ford, US
David M. Burns · Woodbury, US
Hao Feng · Chester, US
Joseph Glenn · Sicklerville, US
Chunhong He · Boothwyn, US
Song Mei · Wilmington, US
Jun Pan · Media, US
Xiaozhao Wang · Readington, US
Yingda Ye · Wilmington, US

Key dates

Filing date	Nov 15, 2019
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Nov 15, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.